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Summary
Midbrain- and hindbrain-derived GABAergic interneurons
are critical for regulation of sleep, respiratory, sensory-motor
and motivational processes, and they are implicated in human
neurological disorders. However, the precise mechanisms that
underlie generation of GABAergic neuron diversity in the
midbrain–hindbrain region are poorly understood. Here, we
show unique and overlapping requirements for the related
bHLH proteins Tal1 and Tal2 in GABAergic neurogenesis in
the midbrain. We show that Tal2 and Tal1 are specifically
and sequentially activated during midbrain GABAergic
neurogenesis. Similar to Gata2, a post-mitotic selector of
the midbrain GABAergic neuron identity, Tal2 expression is
activated very early during GABAergic neuron
differentiation. Although the expression of Tal2 and Gata2
genes are independent of each other, Tal2 is important for
normal midbrain GABAergic neurogenesis, possibly as a
partner of Gata2. In the absence of Tal2, the majority of
midbrain GABAergic neurons switch to a glutamatergic-like
phenotype. In contrast, Tal1 expression is activated in a
Gata2 and Tal2 dependent fashion in the more mature
midbrain GABAergic neuron precursors, but Tal1 alone is
not required for GABAergic neuron differentiation from the
midbrain neuroepithelium. However, inactivation of both
Tal2 and Tal1 in the developing midbrain suggests that the
two factors co-operate to guide GABAergic neuron
differentiation in a specific ventro-lateral midbrain domain.
The observed similarities and differences between Tal1/Tal2
and Gata2 mutants suggest both co-operative and unique
roles for these factors in determination of midbrain
GABAergic neuron identities.
 2013. Published by TheCompany of Biologists Ltd. This is an
Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/
licenses/by/3.0), which permits unrestricted use, distribution
and reproduction in any medium provided that the original
work is properly attributed.
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Introduction
The mammalian midbrain and hindbrain contain neuronal
populations that control motivation, motor and sensory function
as well as vital autonomic activity and sleep.
Gamma-aminobutyric acid (GABA) is the primary inhibitory
neurotransmitter in the mature brain and is used by hundreds of
different types of neurons throughout the central nervous system
(CNS). In the midbrain, distinct GABAergic precursors are generated
in ventro-lateral and dorsal progenitor domains m1–m5 (Nakatani et
al., 2007; Kala et al., 2009). These precursors are thought to contribute
to diversified GABAergic neurons in the midbrain including superior
and inferior colliculi, periaqueductal gray area and nuclei in the
midbrain reticular formation (mRF), where they are involved in
functions such as processing of sensory information (Tsunekawa et al.,
2005; Kala et al., 2009; Peltopuro et al., 2010; Lahti et al., 2013).
Other GABAergic neurons associate with dopaminergic (DA)
nuclei, ventral tegmental area (VTA) and substantia nigra (SN),
in the ventral midbrain. These ventral midbrain GABAergic
neurons (vMB GABAn) are critical for the activity of the DA
pathways and regulation of voluntary movements. Furthermore,
the vMB GABAn embedded in the VTA and rostromedial
tegmental nucleus (RmTg; also called the ‘‘tail of VTA’’) have
recently been found to be central for regulation of motivational
states and reward (Jhou et al., 2009; Kaufling et al., 2010; Hong
et al., 2011; Cohen et al., 2012; Lahti et al., 2013). Thus, the vMB
GABAn are critical for understanding of aetiology and
potentially also treatment of neurological and psychiatric
disease, such as Parkinson’s disease, mood disorders, addiction
and schizophrenia. In contrast to other midbrain GABAergic
neurons, which are derived from the midbrain neuroepithelium,
the vMB GABAn population originates from the rhombomere 1
(r1) neuroepithelium and migrates rostrally to the midbrain as
post-mitotic young neuronal precursors (Achim et al., 2012). In
addition, the GABAergic neurons in the diencephalic part of SN
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have a distinct origin, likely in the more anterior brain regions.
Thus, the developmental history of the midbrain GABAergic
neurons is complex and involves contributions from adjacent
brain regions, especially the r1.
Underlying the segmental organization of diversified
GABAergic neuron development are organizational signals in
the dorsal–ventral and anterior–posterior axes that instruct
expression of transcription factors in distinct and overlapping
patterns (Puelles, 2007; Nakamura et al., 2008). In the midbrain
and posterior diencephalon, a zinc-finger transcription factor
(TF) Gata2 is expressed upon cell cycle exit of all GABAergic
precursors and controls their differentiation (Kala et al., 2009;
Willett and Greene, 2011; Virolainen et al., 2012). Here Gata2
appears to function as a terminal selector gene of the GABAergic
neuron identity. Without Gata2, all the midbrain derived
GABAergic precursors switch to a glutamatergic phenotype. In
contrast to the midbrain, Gata2 is not expressed in the anterior
forebrain GABAergic precursors (Parras et al., 2002; Petryniak et
al., 2007), and while it is expressed in the r1 it is functionally
dispensable for GABAergic neurogenesis, possibly because of
co-expression of Gata3 (Kala et al., 2009; Achim et al., 2012). In
addition to GABAergic neurons, Gata2 and Gata3 are also
expressed in the r1 serotonergic neurons and Gata2 is required for
their development (Craven et al., 2004; Kala et al., 2009).
Gata TFs can exert different and even opposing effects on the
same targets and their functions are highly context-dependent
(Wozniak et al., 2008). These differences can be explained by
participation of other regulatory factors. Indeed, Gata factors
typically function as a part of a multi-protein transcription
regulatory complex that may include Friend of Gata (Fog) family
proteins Fog1 and Fog2, LIM-only TF Lmo2, LIM-family
cofactor Nli (Ldb1), bHLH TF Tal1 (Scl) and others (reviewed
by Cantor and Orkin, 2002; Grosveld et al., 2005). In cultured
blood cell progenitors, the presence or absence of Tal1 in the
Gata2-complex can define the nature of target gene regulation
(Tripic et al., 2009). The Tal1–Gata2 interaction has also been
shown to regulate neuronal fate selection in the ventral spinal
cord (Zhou et al., 2000; Karunaratne et al., 2002; Muroyama et
al., 2005). Here, Tal1 appears to specifically instruct the
development of V2b GABAergic neurons from an initially
bipotent postmitotic precursor pool (Del Barrio et al., 2007; Peng
et al., 2007). The precursor fate segregation also involves a
cofactor Lmo4, which mediates the formation of Gata2–Tal1
transcriptional complex that turns on Gata2/3 expression and
other targets in V2b cells (Joshi et al., 2009).
Although their cell-type specificity has not been demonstrated,
expression of Tal1 and a related gene Tal2 have been detected in
the mouse midbrain and r1 raising the possibility of unique or
overlapping interactions with Gata2 (Elefanty et al., 1999; Mori
et al., 1999; Herberth et al., 2005). Furthermore, conditional
deletion of Tal1 in CNS precursors has been shown to result in a
slight reduction of Tal1 expressing neurons in the midbrain and
more pronounced loss in the hindbrain (Bradley et al., 2006).
Recently, we showed that Tal1 is expressed and required in a
ventral subdomain of the r1 GABAergic precursors (Achim et al.,
2012). Consistent with their origin in the r1, the number of vMB
GABAn are greatly reduced in the Tal1 mutants. Also, Tal2 has
been shown to be important for development of superior and
inferior colliculi (Bucher et al., 2000), although precise cell type
or stage specific roles have not been described.
Here, we established the functions of Tal1 and Tal2 in
GABAergic neurogenesis in the developing midbrain using
single and compound mutant mice. We show that Tal1 and
Tal2, together with Gata2 and Gata3, are activated in spatially
and temporally specific fashion in the differentiating GABAergic
precursors, and that unique functions of these factors are
necessary components of GABAergic sub-type specification in
distinct regions of the developing brain.
Materials and Methods
Mice
The following mouse lines and their genotyping have been described previously:
En1Cre (Kimmel et al., 2000) provided by Wolfgang Wurst, Helmholz Centre
Munich, Germany; Wnt1Cre (Danielian et al., 1998) Jackson Laboratory, Bar
Harbor, USA; Gata2flox (Haugas et al., 2010), Tal1flox (Bradley et al., 2006)
provided by David Curtis Monash University, Melbourne, Australia and Stuart
Orkin, Dana-Farber Cancer Institute, Boston, USA; Tal2null (Bucher et al., 2000)
provided by Terry Rabbitts, MRC Weatheral Institute of Molecular Medicine,
Oxford, UK; and Gad67GFP (Tamamaki et al., 2003) provided by and Yuchio
Yanagawa, Gunma University Graduate School of Medicine, Maebashi, Japan. For
staging, the day of vaginal plug was counted as embryonic day 0.5 (E0.5). For in
situ mRNA hybridization (ISH) and immunohistochemistry (IHC) embryos and
brains were fixed in 4% paraformaldehyde in 16PBS at RT for 2–7 days. Samples
were dehydrated, embedded in paraffin (Merck), sectioned at 5 mm, and collected
on adjacent slides. All analyses were confirmed using 2–5 biological replicates
(e.g. mutant embryos from different litters of same stage). All experiments were
approved by the Laboratory Animal Center of the University of Helsinki, Finland
and the Institutional Animal Care and Use Committee of the University of
California, San Francisco.
In situ mRNA hybridization and immunohistochemistry
mRNA ISH analyses on paraffin sections were performed as described previously
(Wilkinson and Green, 1990) using 35S- or digoxigenin-labeled cRNA probes. IHC
was performed as described previously (Kala et al., 2008). For combined ISH and
IHC, TSA Fluorescence Palette System (PerkinElmer) was used to visualize ISH
signal. Additional primary antibodies were added after the ISH signal detection.
For defining of the domain boundaries in the midbrain (m3–m5), adjacent sections
were analysed for Helt, Nkx2.2 and Nkx6.1 expression. Detailed ISH and IHC
protocols are available upon request.
Mouse cDNA probes used for ISH analysis were: Gad1 (Gad67), Slc17a6
(Vglut2) (Guimera et al., 2006), Gata2, Gata3 (Lilleva¨li et al., 2004), Six3
(IMAGE 761326), Tal1 (IMAGE 6826611) Tal1flox (detects specifically the Tal1
transcript from the wild-type or unrecombined locus; contains the sequences
between the LoxP sites in the Tal1flox allele (nt 699–1104 of NM_011527)), Tal2
(IMAGE 40051579). Following antibodies were used in IHC stainings: rabbit anti-
Gata2 (Santa Cruz sc-9008, 1:250), mouse anti-Gata3 (Santa Cruz sc-268, 1:200),
goat anti-GFP (Abcam ab6673, 1:500), rabbit anti-GFP (Abcam ab290, 1:500),
guinea pig anti-Heslike (Helt, 1:500; gift from Ryoichiro Kageyama, Institute for
Virus Research, Kyoto University, Japan), mouse anti-HuC/D (Molecular Probes
A21271, 1:1000), goat anti-Otx2 (R&D Systems BAF1979, 1:200), mouse anti-
Ascl1 (BD Biosciences 556604, 1:200), mouse anti-Nkx2-2 (DSHB 74.5A5,
1:250), mouse anti-Nkx6.1 (1:1000, DSHB F55A10), mouse anti-Sox2 (Millipore
AB5603, 1:400), mouse anti-TH (Millipore MAB318, 1:800), rabbit anti-5-HT
(Immunostar 20080, 1:1500). Alexa-488 and Alexa-568 conjugated goat anti-
rabbit IgG and anti-mouse IgG, donkey anti-rabbit IgG, anti-mouse IgG and anti-
goat IgG (1:400, Invitrogen) were used as secondary antibodies.
Microscopy
IHC and ISH staining on paraffin sections were visualized with an Olympus AX70
microscope with Olympus DP70 camera or a Zeiss Axioimager M2 microscope
with Axiocam HRc camera. Images were processed and assembled with Adobe
Photoshop software. Confocal images were taken as snapshots with Leica SP5
confocal microscope.
Results
Tal1 and Tal2 are co-expressed with Gata2 in developing
GABAergic neurons of the midbrain and r1
We first analysed the expression of Tal genes in the wild-type
midbrain and r1 regions by ISH during GABAergic neurogenesis
at E10.5–E12.5. In the midbrain, we detected Tal2 expression in
the ventricular zone (VZ) and intermediate zone (IZ; Fig. 1C,H,
Fig. 2A, Fig. 3A,C,F), while Tal1 was confined to the IZ and
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mantle zone (MZ; Fig. 1B,G, Fig. 2B, Fig. 3B,D). In addition,
both Tal1 and Tal2 were expressed in the GFP+ GABAergic
neurons in the Gad67GFP/+ mouse embryos (Fig. 2A–D). In
contrast to the midbrain, Tal2 expression was very low and
restricted to a small IZ area in the anterior r1 (Fig. 2L,M) while
Tal1 expression in r1 was robust and extended from the VZ to
MZ (Fig. 2J,K, Fig. 3E).
In both midbrain and r1, expression domains of Tal1/2 and
Gata2/3 appeared to overlap extensively (Fig. 1, Fig. 2J–S), with
the exception of Gata2/3+ serotonergic neuron precursors in the
r1 (Fig. 2K,M,O,Q,S,T). To further study the co-expression of
Tal1/2 and Gata2/3, we combined ISH for Tal1/2 and IHC for
Gata2/3. This showed that in the midbrain, Gata2 is nearly
exclusively co-expressed with Tal2 in the VZ and IZ (Fig. 2E).
Fig. 1. Expression of Tal and Gata factors in the wild-type
and Tal1cko midbrain. ISH analysis of Gad1, Tal1, Tal2, Gata2,
and Gata3 expression on adjacent coronal sections of WT (A–J)
and Tal1cko (K–O) midbrains at E10.5–E11.5. Radioactive ISH
in panels A–E, non-radioactive in the others. The development of
GABAergic neurons remains unaffected in the Tal1cko midbrain.
Tal1flox probe (G,L) was designed to recognize the region
between LoxP sites in the conditional allele and therefore the loss
of signal in the Tal1cko midbrain demonstrates efficient
inactivation of the Tal1 gene.
Fig. 2. Expression of Tal and Gata factors in the developing midbrain and
r1. (A–H) Co-expression of Tal2 and Tal1 (ISH) with Gad67-driven GFP,
Gata2, and Gata3 in coronal sections of E11.5 midbrains. Epifluorescence
images in (A,B,E–H), confocal images in (C,D). (I) The planes of sectioning.
(J–S) Radioactive ISH with the probes indicated adjacent coronal sections from
E11.5 midbrain–r1 (J,L,N,P,R). The dashed line indicates the midbrain–r1
border, defined by the anti-Otx2 staining on an adjacent section (not shown).
(K,M,O,Q,S) Radioactive ISH with the probes indicated on parallel transverse
sections from E12.5 rhombomere 1 area. The dashed lines mark the ventral and
dorsal borders of Nkx6.1 expression domain in r1 (not shown). The serotonergic
domain (SA) was detected using with an anti-5HT antibody on a parallel
section (T). r1, rhombomere 1, mb, midbrain. White arrowheads in C–H
indicate co-expression, arrowheads in K–T point to serotonergic neurons. Scale
bars: 100 mm (A,J), 25 mm (C), 200 mm (K).
Fig. 3. Expression of Tal factors in the intermediate and mantle zones of
the midbrain. (A,B) Fluorescent ISH with Tal1 and Tal2 probes combined
with p57 IHC on E11.5 ventral midbrain. The positions of three zones were
deduced from the p57+ cells, which mark the intermediate zone.
(C–E) Fluorescent ISH with Tal1 and Tal2, and IHC with a pan-neuronal
marker HuC/D on E11.5 ventral midbrain. (F,G) Fluorescent ISH with Tal2 and
IHC with ventricular zone marker Sox2 on E11.5 wild-type and Gata2cko
ventral midbrain, with domain borders indicated. The dashed line visualizes the
border between ventricular zone and mantle zone, based on Sox2 staining. VZ,
ventricular zone; IZ, intermediate zone; MZ, mantle zone; mb, midbrain; r1,
rhombomere 1. Scale bars: 25 mm (A–E), 100 mm (F,G).
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Tal1 is activated later during differentiation, and thus Gata2 and
Tal1 are co-expressed in the IZ (Fig. 2F). Tal1 positive cells in
the MZ most abundantly expressed Gata3 (Fig. 2H). In contrast,
we detected only little co-expression of Tal2 and Gata3 in the MZ
(Fig. 2G). Both Tal1 and Tal2 were detected in postmitotic (HuC/
D+) neurons (Fig. 3C,D). In the r1, the weak expression of Tal2
precluded fluorescent ISH-based co-localization studies.
However, radioactive ISH demonstrated that Tal2 expression
was mostly confined to the IZ in the r1 (Fig. 2M). In contrast to
the midbrain, Tal1 expression was detected already in the VZ and
early during post-mitotic differentiation of the r1 GABAergic
neurons (Fig. 2K, Fig. 3E). In summary, Tal1 and Tal2
specifically mark the midbrain and r1 GABAergic precursors
and co-localize with Gata2 and Gata3. However, the dynamics of
Tal1 and Tal2 expression differ between the midbrain and r1.
While Tal2 expression precedes Tal1 in the midbrain, the
opposite is observed in the r1 where Tal1 is expressed at an
earlier stage and co-expressed with Gata2 already in the VZ.
Gata2 is required for the expression of Tal1 but not Tal2 in the
midbrain
To study if activation of Tal1 and/or Tal2 requires Gata2
function, we analysed En1Cre; Gata2flox/flox (Gata2cko) mutants in
which both midbrain and r1 are devoid of Gata2 expression (Kala
et al., 2009). In the Gata2cko midbrain, Tal1 was downregulated
at E12.5 (Fig. 4C,D) together with GABAergic neuron markers
Gad1, Gata3 and Six3 (Fig. 4A,B and data not shown). In
contrast, we detected persistent Tal2 mRNA expression
(Fig. 4E,F, Fig. 3G). In the r1, expression of Gad1 and Tal1/2
was not affected by the loss of Gata2 function (Fig. 4B,D,F and
data not shown), indicating that Gata2 is required for Tal1
expression in the midbrain but not in the r1, while Tal2
expression is Gata2-independent, at least in the midbrain.
We also analysed Gad1, Tal1 and Tal2 expression in wild-type
and Gata2cko midbrains at E15.5 (Fig. 4G–L). Consistent with
expression of Tal1 in the MZ at E12.5, Tal1 was abundantly
expressed in the wild-type midbrain regions containing
GABAergic neurons. In contrast, the expression of Tal2 was
restricted to the VZ/IZ of the most dorsal midbrain, where
GABAergic neurogenesis continues later than in the ventro-
lateral regions (Achim et al., 2012). In the Gata2cko midbrain,
Tal1 expression was abolished, except for the r1-derived
GABAergic neurons in the SNpr (Fig. 4I,J). As in the ventro-
lateral midbrain at E12.5, Tal2 was still expressed in the dorsal
midbrain of Gata2cko mutants at E15.5, although its pattern
of expression was more narrow suggesting more rapid
downregulation in the IZ (Fig. 4K,K9,L,L9).
Tal factors are required to activate genes characteristic for
differentiating GABAergic neurons in the midbrain
To elucidate the importance of different Tal factors in regulation of
GABAergic neuron differentiation in the midbrain and r1, we
studied the expression of several genes characteristic to midbrain
and r1 GABAergic neurons (Gata2, Gata3, Tal1, Six3, Gad1) in
embryos mutant for Tal2 (Tal2null/null5Tal2ko), Tal1 (En1cre/+;
Tal1flox/flox5Tal1cko), or both Tal1 and Tal2 (Wnt1cre/+; Tal1flox/flox;
Tal2null/null5Tal1/2dko) in comparison with the Gata2cko mutants.
Wnt1Crewas used for inactivation in Tal1/2dko double mutants due to
availability of the mouse strains. In the Tal1cko mutants, En1cre-
mediated inactivation of Tal1flox allele occurs throughout the
midbrain and r1. In the Tal1/2dko, the Tal1flox allele is inactivated
by Wnt1cre, which is active mostly in the midbrain. Both Wnt1cre-
and En1cre-mediated recombination is complete by E8.5, well
before the onset of neuronal differentiation (Trokovic et al., 2003).
We detected no Tal1 expression in the midbrain and r1 of the Tal1cko
or Tal1/2dko embryos at E11.5–E12.5 (Fig. 1L and data not shown).
At E11.5, inactivation of Tal1 alone (Tal1cko) did not affect
GABAergic neurogenesis or the expression ofGata2,Gata3 or Tal2
in the midbrain (Fig. 1K–O).
The VZ progenitors in the midbrain GABAergic regions
appeared unaffected also in the Tal2ko (supplementary material
Fig. S1) and Gata2 expression was maintained in the early
postmitotic precursors at E11.5 (Fig. 5H). In contrast, other post-
mitotic GABAergic precursor specific genes were largely
downregulated, in Tal2ko embryos (Fig. 5I–L). However, in
contrast to Gata2cko, some Gad1+ and Gata3+ cells were still
detected in the Tal2ko embryos, especially in the m5 domain
(Fig. 5I,L, arrowheads).
Although Tal1 expression was downregulated in the Tal2ko
brains at E11.5 (Fig. 5J), and Tal1 inactivation alone did not
affect GABAergic neurogenesis in the midbrain (Fig. 1K–O)
(Achim et al., 2012), it is possible that its expression at an earlier
stage or at an undetectable level accounts for the survival of the
few GABAergic cells observed in the Tal2ko mutants. To address
this possible redundancy, we analyzed the Tal1/2dko double
mutant midbrains. In these mutants, Gad1 expression was lost
completely in E11.5 midbrain (Fig. 5R), along with the
GABAergic markers Six3 and Sox14 (Fig. 5Q and data not
shown). However, we still detected Gata3 expressing cells in the
Fig. 4. Tal1 and Tal2 expression in the Gata2mutants. ISH analysis of Gad1
(A,B,G,H), Tal1 (C,D,I,J) and Tal2 (E,F,K,L) expression in wild-type (WT)
and Gata2cko embryos at E12.5 and at E15.5. Note that the expression of Tal2
in the r1 is below the detection level by these non-radioactive ISH experiments.
The dashed line indicates the midbrain/r1 border, detected by Otx2 staining on
a parallel section (data not shown). Arrowheads point to the SNpr, defined by
TH immunostaining on adjacent sections (not shown). Arrows point to Tal2
expression domain in the dorsal midbrain (close up images in insets, K9 and
L9). mb, midbrain; r1, rhombomere 1; PAG, periaqueductal grey; mRF,
midbrain reticular formation; SNpr, substantia nigra pars reticulata, SC,
superior colliculi. Scale bars: 200 mm.
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m5 domain of the Tal1/2dko midbrains (Fig. 5O), suggesting that
the loss of GABAergic identity was still incomplete at least in
this domain. Importantly, Gata2 expression was unaffected in
the Tal1/2dko (Fig. 3N), and the early GABAergic markers Helt
(Fig. 5M) and Ascl1 (supplementary material Fig. S1) were
detected in the VZ, confirming that the absence of Tal factors
results in alterations only at the postmitotic differentiation
stage.
In summary, our results suggest that Tal2 and Gata2 do not
require each other for their expression but are independently
activated in the midbrain and both control genes required for
complete GABAergic differentiation and for the acquisition of
correct neuronal identity. In addition, whereas Gata2 is required
for GABAergic neurogenesis in the entire midbrain, requirement
for the Tal factors for GABAergic development varies between
the midbrain subdomains.
Ectopic activation of glutamatergic neuron markers in Tal
mutant midbrain
Concomitant to loss of GABAergic markers, we observed ectopic
upregulation of glutamatergic neuron markers Pax6 and Slc17a6
(Fig. 6E,F). These results indicate a GABAergic-to-glutamatergic
fate transformation specifically in the midbrain of Tal2ko mutants,
similar to the Gata2cko phenotype in the midbrain (Kala et al.,
2009). However, unlike in Gata2cko mutants where only the m4v
domain transforms to Pax6 expressing glutamatergic neurons
whereas the m3 domain starts expressing m1–m2 glutamatergic
marker Pou4f1 (Kala et al., 2009), in Tal2ko mutants ectopic Pax6
positive cells can be detected extensively in both m4d and m3
domains (Fig. 6E, arrowheads). Similar to the Tal2ko mutants,
Pax6 and Slc17a6 expression was upregulated in Tal1/2dko
midbrain compared to wild type (Fig. 6H,I). In the wild type,
Nkx6.1 is expressed in the VZ of domains m6, m5 and m3 and in
the glutamatergic postmitotic precursors in m6. Nkx6.1 did not
display ectopic expression in postmitotic Pax6 positive precursors
derived from m4 or m3 in either Tal2ko or Tal1/2dko midbrains
(Fig. 6A,D,G, arrows). However, especially in the Tal1/2dko
mutants, Nkx6.1 expression appeared somewhat expanded in the
postmitotic precursors in the m5 domain, similar to what has been
observed in Gata2cko (Kala et al., 2009).
Thus, the Tal factors, and especially Tal2, appear to operate as
post-mitotic selectors between GABAergic and glutamatergic
neuronal phenotypes in the midbrain. In this respect, they share
the function of their putative cofactor Gata2. However, Tal and
Gata factors also differ in the ways they affect development of
neuronal precursors derived from distinct midbrain regions.
Loss of Tal2 and Gata2 results in changes in neuronal identities
in the nuclei of perinatal midbrain
Next, we compared the expression of GABAergic and
glutamatergic neuron markers in the midbrains of Gata2cko and
Tal2ko mutants at perinatal stages. Normally, both Gad1+
GABAergic neurons and Slc17a6+ glutamatergic neurons are
found in a variety of nuclei across midbrain (Fig. 7A,B,D). At
E15.5–P0, Gad1+ neurons co-expressed Gata3 and Tal1 in
Fig. 5. GABAergic gene expression in Tal2 and Tal1/2dko mutant
midbrains. Expression of Helt (IHC), Gata2, Gata3, Tal1, Six3 and Gad1
(ISH) on coronal sections of E11.5 wild-type (A–F), Tal2ko (G–L) and Tal1/
2dko (M–R) midbrains. The dashed lines indicate the borders of midbrain
m3–m5 domains, defined by Helt and Nkx2.2 stainings on parallel sections (not
shown). The arrowheads point to the m5 domain, where fate transformation
appears to be incomplete. Scale bar: 100 mm.
Fig. 6. Glutamatergic gene expression in Tal2 and Tal1/2dko mutant
midbrains. Expression of Nkx6.1 (A,D,G), Pax6 (B,E,H) and Scl17a6
(C,F,I) on coronal sections of E11.5 wild-type (A–C), Tal2ko (D–F) and
Tal1/2dko (G–I) midbrains. The dashed lines indicating the borders of m3–m5
domains were defined by Helt and Nkx2.2 stainings on parallel sections (not
shown). Arrowheads point to ectopic expression. Arrows in panels D and G
indicate areas where ectopic Pax6 expression is seen on a parallel section. Scale
bars: 100 mm.
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specific nuclei and midbrain regions including the SN (Fig. 4G,I,
Fig. 7B,C and data not shown). In both Gata2cko and Tal2ko
animals, GABAergic markers were completely lost in the dorsal
midbrain including the superior colliculi (Fig. 7A,F,K and data
not shown). Similarly, we found that Tal2ko greatly resembles
Gata2cko in that the expression of GABAergic markers Gad1
(Fig. 7B,G,L), Gata3 and Tal1 (Fig. 7C,H,M and data not
shown) was lost (Gata2cko) or reduced (Tal2ko) in the mRF.
Furthermore, in the SN/VTA marked by TH staining
(Fig. 7E,J,O), Gad1, Gata3 and Tal1 expressing cells were
retained both in the Gata2cko and Tal2ko (Fig. 7B,C,G,H,L,M,
arrowheads, and data not shown). Consistent with cell fate
re-specification, upregulation of Slc17a6 was observed in the
mRF region but not in SN/VTA of Gata2cko and Tal2ko midbrains
(Fig. 7D,I,N). Similar changes were seen in Tal1/2dko
(supplementary material Figs S2, S3; note for example the
glutamatergic red nucleus (RN) which is surrounded by mostly
GABAergic neurons in the wild type, but glutamatergic neurons
in the mutants in supplementary material Fig. S3B,C,E,F). Thus,
the perinatal Tal2 and Gata2 mutants display neuronal fate
changes, which are consistent with their embryonic phenotypes.
Furthermore, in contrast to Tal1 (Achim et al., 2012), Tal2 or
Gata2 are not required by the majority of vMB GABAn.
Discussion
Knowledge of developmental regulatory mechanisms can provide
key insights into generation of neuronal diversity and functional
specialization in the CNS. Such mechanisms might also be
involved in developmental anomalies leading to life-threatening
human neurological disorders. For example, mutation of
transcription factor PTF1A in humans results in abnormal
development of GABAergic neurons in the dorsal r1 and
cerebellar agenesis (Sellick et al., 2004; Hoshino et al., 2005).
Development of GABAergic neurons is regulated by different
molecular mechanisms in different parts of the developing CNS.
Our previous studies identified Gata2 as a post-mitotic terminal
selector gene during GABAergic neurogenesis in the embryonic
midbrain and revealed developmental diversity of the distinct
GABAergic neuron groups in the midbrain–r1 region (Kala et al.,
2009; Achim et al., 2012). Here, we studied how the putative
cofactors of Gata2, Tal1 and Tal2, are involved in the
GABAergic neuron differentiation in the midbrain. Our results
suggest that Tal2 is important for selection of GABAergic over
glutamatergic neuron identity in the midbrain. In contrast, Tal1
marks more mature midbrain GABAergic precursors but is not
required for their differentiation. Unlike Gata2, the requirement
for Tal factors varies between the midbrain subregions. The
ventro-lateral m5 domain appears the most tolerant to Tal2
inactivation. Here, Tal1 and Tal2 may function redundantly to
regulate GABAergic neurogenesis (Fig. 8).
Similarities and differences of Gata and Tal factors as the
terminal selectors of GABAergic identity
Studies on neuronal differentiation in various models, including
C. elegans, have led to the concept of terminal selector genes
(Hobert, 2011). These genes are thought to be active in post-
mitotic neuronal precursors and regulate expression of gene
batteries providing a neuron its identity. An important feature of
a terminal selector gene is that its inactivation does not lead to the
loss of the neuron but rather the loss, or transformation, of its
identity. Our previous studies have suggested that Gata2 fulfils
most of the criteria of a terminal selector gene both in the
developing midbrain and diencephalon (Kala et al., 2009;
Virolainen et al., 2012). The results presented here suggest that
the selection of the GABAergic identity also requires Tal2 in the
developing midbrain. As Gata and Tal factors are involved in the
Fig. 7. GABAergic and glutamatergic marker gene expression in the
Gata2cko and Tal2ko perinatal brain. The expression of Gad1, Tal1 and
Slc17a6 (ISH) was analyzed on coronal sections through the WT (A–D),
Gata2cko (F–I), and Tal2ko (K–N) midbrains at P0. TH IHC on adjacent
sections (E,J,O) was used as a landmark to identify the midbrain region and
define the SN/VTA nuclei. The arrowheads point to SN, the arrow to mRF.
Scale bars: 200 mm.
Fig. 8. Model of Gata/Tal terminal selector complex and its variants in the
midbrain. A schematic cross-section of E12.5 midbrain, with the domains
generating GABAergic neurons indicated in green. Both Gata2 and Tal2
expression is initiated after cell cycle exit. Coincident expression of Gata2 and
Tal2 leads to formation of a terminal selector complex crucial for the correct
GABAergic identity development in m1–4d. In m5, Tal1 is also required. VZ,
ventricular zone; IZ, intermediate zone; MZ, mantle zone; SA, serotonergic
domain.
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same transcriptional complexes in other tissues, they may also
form an analogous TF complex in the midbrain. Our results
suggest that expression of both Gata2 and Tal2 is initiated very
early after cell cycle exit and further demonstrate independent
initiation of Tal2 and Gata2 expression, likely triggered by
region- and cell-cycle stage specific cues. However, neither the
endogenous Tal2 nor Gata2 alone are sufficient to induce all
GABAergic neuron specific genes in the embryonic midbrain.
Instead, we propose that the coincident expression of these two
TFs leads to formation of a terminal selector complex of the
GABAergic identity (Fig. 8).
Consistent with the hypothesis above, the midbrain phenotypes
of Gata2 and Tal2 mutants are similar. In both cases progenitor
proliferation, cell cycle exit and production of neuronal
precursors appeared undisturbed, but the postmitotic precursors
lost their GABAergic identity and acquired glutamategic
characteristics instead. However, there also are some notable
differences. In contrast to Gata2 mutants, the GABAergic marker
genes are not completely lost in the Tal2 mutants. In particular,
the m5 domain still retains some of its GABAergic characteristics
without Tal2. Studies of the Tal1/2dko mutants suggest that this is
partly explained by redundancy between Tal2 and Tal1.
However, some GABAergic markers, such as Gata3, were
detected in m5 even in the absence of both Tal1 and Tal2.
In the m3 domain, pronounced GABAergic-to-glutamatergic
phenotypic transformation occurs in both Tal2 and Gata2
mutants. However, the ectopic glutamatergic neurons appear to
be of different subtype in the two mutants. Without Gata2, the
precursors produced in m3 upregulate Pou4f1, resembling the
glutamatergic neurons born in m1 and m2 (Kala et al., 2009). In
contrast, in the Tal2 mutants, the ectopic glutamatergic neurons
in m3 are positive for Pax6, similar to the glutamatergic neurons
produced in m4v. Thus, in addition to the putative Gata2–Tal2
complex, the two factors may also have functions independent of
each other or their loss can be differentially compensated by
other associating factors.
Distinct Gata/Tal complexes regulate GABAergic neurons in
different spatio-temporal patterns?
Gata2/3 and Tal1/2 also mark a subset of differentiating
GABAergic neurons in the r1. Ventrally this GABAergic
subdomain is bordered by Nkx2.2 positive serotonergic region
and dorsally it extends to the dorsal boundary of Nkx6.1
expression (Achim et al., 2012). However, requirement for the
Gata and Tal factors in the r1 is different from the midbrain. In
contrast to the midbrain, Tal1 is required for GABAergic
differentiation in the rhombomere 1 (Achim et al., 2012).
Similar to Tal2 in the midbrain, Tal1 may perform the selector
function in a complex together with Gata factors. It is likely that
this variation is used for generating GABAergic neuron
subpopulations, which differ in their gene expression patterns
and cellular phenotypes.
As discussed above, the Gata and Tal TFs may also operate
independent of each other in distinct gene regulatory complexes.
This is particularly evident in the r1, where Gata2 and Gata3 are
strongly expressed in the developing serotonergic neurons
without any detectable Tal1 or Tal2. Therefore, the TF
complex regulating serotonergic neuron differentiation must
differ from the one regulating the GABAergic phenotype. It
will be of interest to analyse whether Gata2 and Gata3 also
perform a terminal selector gene function in the serotonergic
neuron lineage. If this is the case, Tal1, Tal2 and additional Gata
cofactors may differentiate between serotonergic and GABAergic
lineages.
Conclusions
Here we demonstrate distinct requirements for the putative Gata
cofactors Tal2 and Tal1 in differentiating GABAergic neurons in
the midbrain. We suggest that variants of Gata–Tal complex
function as terminal selectors identifying different types of post-
mitotic GABAergic precursors. Although Gata2 and Tal2/Tal1
likely co-operate as GABAergic neuron determinants, differences
in the midbrain neuronal differentiation in the absence of Gata2
or Tal1/2 function also suggest that these factors have unique
targets. Knowledge on developmental regulation of the
subgroups of GABAergic neurons in the midbrain–r1 region
will allow later studies of their molecular composition,
morphology and function.
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